Integrated Filing — IndAS



General information about company
Scrip Code 532890
NSE Symbol TAKE
MSEI Symbol NA
ISIN INE142I01023
Name of company TAKE SOLUTIONS LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-Apr-2024
Date of end of financial year 31-Mar-2025
Date of board meeting when results were approved 30-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 23-May-2025
Description of presentation currency INR (in Actuals)
Reporting Type Half Yearly
Reporting Quarter Yearly
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Single segment
Description of single segment Life Sciences
Start date and time of board meeting 30-May-2025   13:00:00
End date and time of board meeting 30-May-2025   16:20:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Statement on impact of audit qualification
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 2022-04-01
Indicate Company website link for updated RPT policy of the Company https://www.takesolutions.com/images/corporate_governance1/policy-on-related-party-transactions.pdf
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
Not Applicable



Financial Results Ind-AS
Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Oct-2024 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Part I Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1 Income
Revenue from operations 0 8990000
Other income 108740000 129760000
Total income 108740000 138750000
2 Expenses
(a) Cost of materials consumed 0 0
(b) Purchases of stock-in-trade 0 0
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade 0 0
(d) Employee benefit expense 1400000 10620000
(e) Finance costs 2030000 7440000
(f) Depreciation, depletion and amortisation expense 100000 450000
(f) Other Expenses
1 Other Expenses 5600000 18950000
Total other expenses 5600000 18950000
Total expenses 9130000 37460000
3 Total profit before exceptional items and tax 99610000 101290000
4 Exceptional items 0 0
5 Total profit before tax 99610000 101290000
6 Tax expense
7 Current tax 0 0
8 Deferred tax 0 0
9 Total tax expenses 0 0
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0 0
11 Net Profit Loss for the period from continuing operations 99610000 101290000
12 Profit (loss) from discontinued operations before tax -51840000 -798650000
13 Tax expense of discontinued operations 0 0
14 Net profit (loss) from discontinued operation after tax -51840000 -798650000
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0 0
16 Total profit (loss) for period 47770000 -697360000
17 Other comprehensive income net of taxes 210000 870000
18 Total Comprehensive Income for the period 47980000 -696490000
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 147930000 147930000
Face value of equity share capital 1 1
27 Details of debt securities
22 Reserves excluding revaluation reserve 0
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 0.67 0.68
Diluted earnings (loss) per share from continuing operations 0.67 0.68
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations -0.35 -5.4
Diluted earnings (loss) per share from discontinued operations -0.35 -5.4
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 0.32 -4.72
Diluted earnings (loss) per share from continuing and discontinued operations 0.32 -4.72
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results



Remarks
Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities
Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-Apr-2024
Date of end of reporting period 31-Mar-2025
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 0
Capital work-in-progress 0
Investment property 0
Goodwill 0
Other intangible assets 80000
Intangible assets under development 0
Biological assets other than bearer plants 0
Investments accounted for using equity method 0
Non-current financial assets
Non-current investments 0
Trade receivables, non-current 0
Loans, non-current 0
Other non-current financial assets 0
Total non-current financial assets 0
Deferred tax assets (net) 0
Other non-current assets 92010000
Total non-current assets 92090000
2 Current assets
Inventories 0
Current financial asset
Current investments 0
Trade receivables, current 0
Cash and cash equivalents 31570000
Bank balance other than cash and cash equivalents 600000
Loans, current 0
Other current financial assets 138730000
Total current financial assets 170900000
Current tax assets (net) 0
Other current assets 53630000
Total current assets 224530000
3 Non-current assets classified as held for sale 0
4 Regulatory deferral account debit balances and related deferred tax Assets 0
Total assets 316620000
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 147930000
Other equity 109740000
Total equity attributable to owners of parent 257670000
Non controlling interest
Total equity 257670000
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 0
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises 0
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 0
Total Trade payable 0
Other non-current financial liabilities 0
Total non-current financial liabilities 0
Provisions, non-current -20000
Deferred tax liabilities (net) 0
Deferred government grants, Non-current 0
Other non-current liabilities 0
Total non-current liabilities -20000
Current liabilities
Current financial liabilities
Borrowings, current 0
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 210000
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 1900000
Total Trade payable 2110000
Other current financial liabilities 6500000
Total current financial liabilities 8610000
Other current liabilities 48130000
Provisions, current 2230000
Current tax liabilities (Net) 0
Deferred government grants, Current 0
Total current liabilities 58970000
3 Liabilities directly associated with assets in disposal group classified as held for sale 0
4 Regulatory deferral account credit balances and related deferred tax liability 0
Total liabilities 58950000
Total equity and liabilites 316620000
Disclosure of notes on assets and liabilities



Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-Oct-2024 01-Apr-2024
Date of end of reporting period 31-Mar-2025 31-Mar-2025
Whether accounts are audited or unaudited Audited Audited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income
Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Oct-2024 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Items that will not be reclassified to profit or loss 210000 870000
Total Amount of items that will not be reclassified to profit and loss 210000 870000
2 Income tax relating to items that will not be reclassified to profit or loss 0 0
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss 0 0
5 Total Other comprehensive income 210000 870000



Cash flow statement, indirect
Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-Apr-2024
B Date of end of reporting period 31-Mar-2025
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Standalone
Part I Blue color marked fields are non-mandatory.
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 101290000
Adjustments for reconcile profit (loss)
Adjustments for finance costs 7440000
Adjustments for decrease (increase) in inventories 0
Adjustments for decrease (increase) in trade receivables, current 0
Adjustments for decrease (increase) in trade receivables, non-current 0
Adjustments for decrease (increase) in other current assets 8480000
Adjustments for decrease (increase) in other non-current assets 0
Adjustments for other financial assets, non-current 0
Adjustments for other financial assets, current -137090000
Adjustments for other bank balances 0
Adjustments for increase (decrease) in trade payables, current -2940000
Adjustments for increase (decrease) in trade payables, non-current 0
Adjustments for increase (decrease) in other current liabilities 3460000
Adjustments for increase (decrease) in other non-current liabilities 0
Adjustments for depreciation and amortisation expense 450000
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0
Adjustments for provisions, current 90000
Adjustments for provisions, non-current 0
Adjustments for other financial liabilities, current -49720000
Adjustments for other financial liabilities, non-current 0
Adjustments for unrealised foreign exchange losses gains 0
Adjustments for dividend income 0
Adjustments for interest income 1860000
Adjustments for share-based payments 0
Adjustments for fair value losses (gains) 0
Adjustments for undistributed profits of associates 0
Other adjustments for which cash effects are investing or financing cash flow 0
Other adjustments to reconcile profit (loss) 0
Other adjustments for non-cash items -39260000
Share of profit and loss from partnership firm or association of persons or limited liability partnerships -88270000
Total adjustments for reconcile profit (loss) -299220000
Net cash flows from (used in) operations -197930000
Dividends received 0
Interest paid 0
Interest received 0
Income taxes paid (refund) -2860000
Other inflows (outflows) of cash 0
Net cash flows from (used in) operating activities -195070000
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0
Cash flows used in obtaining control of subsidiaries or other businesses 0
Other cash receipts from sales of equity or debt instruments of other entities 0
Other cash payments to acquire equity or debt instruments of other entities 0
Other cash receipts from sales of interests in joint ventures 0
Other cash payments to acquire interests in joint ventures 0
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0
Proceeds from sales of property, plant and equipment 0
Purchase of property, plant and equipment 0
Proceeds from sales of investment property 219810000
Purchase of investment property 0
Proceeds from sales of intangible assets 0
Purchase of intangible assets 0
Proceeds from sales of intangible assets under development 0
Purchase of intangible assets under development 0
Proceeds from sales of goodwill 0
Purchase of goodwill 0
Proceeds from biological assets other than bearer plants 0
Purchase of biological assets other than bearer plants 0
Proceeds from government grants 0
Proceeds from sales of other long-term assets 0
Purchase of other long-term assets 0
Cash advances and loans made to other parties 0
Cash receipts from repayment of advances and loans made to other parties 0
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0
Dividends received 0
Interest received 0
Income taxes paid (refund) 0
Other inflows (outflows) of cash 2250000
Net cash flows from (used in) investing activities 222060000
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0
Payments from changes in ownership interests in subsidiaries 0
Proceeds from issuing shares 0
Proceeds from issuing other equity instruments 0
Payments to acquire or redeem entity's shares 0
Payments of other equity instruments 0
Proceeds from exercise of stock options 0
Proceeds from issuing debentures notes bonds etc 0
Proceeds from borrowings 0
Repayments of borrowings 0
Payments of lease liabilities 0
Dividends paid 390000
Interest paid 0
Income taxes paid (refund) 0
Other inflows (outflows) of cash 0
Net cash flows from (used in) financing activities -390000
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes 26600000
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0
Net increase (decrease) in cash and cash equivalents 26600000
Cash and cash equivalents cash flow statement at beginning of period 4970000
Cash and cash equivalents cash flow statement at end of period 31570000





Details of Impact of Audit Qualification
Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Statement on impact of audit qualification
Auditor's opinion Qualified opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 Sundar Srini & Sridhar Yes 30-Jun-2027


Financial details
Sr. Particulars Audited Figures (as reported before adjusting for qualifications) Adjusted Figures (audited figures after adjusting for qualifications)
1 Turnover / Total income 138750000 138750000
2 Total Expenditure 37460000 37460000
3 Net Profit/(Loss) -697360000 -697360000
4 Earnings Per Share -4.72 -4.72
5 Total Assets 316620000 316620000
6 Total Liabilities 316620000 316620000
7 Net Worth 257670000 257670000
8 Any other financial item(s) (Profit/(Loss) from Discontinued Operations) -798650000 -798650000


Audit qualification
Sr. Details of Audit Qualification Type of Audit Qualification Frequency of qualification For Audit Qualification(s) where the impact is quantified by the auditor For Audit Qualification(s) where the impact is not quantified by the auditor
Management's Views (i) Management's estimation on the impact of audit qualification (ii) If management is unable to estimate the impact, reasons for the same Auditors' Comments on (i) or (ii) above
1 Textual Information(1) Qualified opinion Since how long continuing Textual Information(2) Textual Information(3) Textual Information(4) Textual Information(5)
2 Textual Information(6) Qualified opinion Since how long continuing Textual Information(7) Textual Information(8) Textual Information(9) Textual Information(10)
3 Textual Information(11) Qualified opinion Since how long continuing Textual Information(12) Textual Information(13) Textual Information(14) Textual Information(15)


Text Block
Textual Information(1) As stated in Note No. 5 to the statement, tax assets appearing in the standalone financial statements of the Company to an extent of INR 88.32 Million pertain to various assessment years relating to the financial periods ending upto March 31, 2021. In the absence of sufficient appropriate evidence to corroborate managements assessment of recoverability of these balances, we are unable to comment on the carrying value of above receivables and the shortfall, if any, on the amount that would be ultimately realizable from the tax authorities considering the fact that the Companys contingent liabilities as at 31 March 2025 include contingent liabilities aggregating to INR 108.03 Million pertaining to direct tax litigations pending before various forums relating to the above periods, for which the assessment on whether the outflow of resource embodying economic benefits is probable or not as per the requirements of Ind AS 37- Provisions, Contingent Liabilities and Contingent Assets is in progress. In the absence of sufficient appropriate audit evidence, we are unable to comment upon the appropriateness and classification of the aforesaid amounts as provision or contingent liabilities as at 31 March 2025 in accordance with Ind AS 37, Provisions, Contingent Liabilities and Contingent Assets and the consequential impact, if any, on the total liabilities and loss as at and for the year then ended.
Textual Information(2) Not Applicable
Textual Information(3) Not Applicable
Textual Information(4) Tax Assets to an extent of Rs. 88.32 Million recognised in the standalone financial statements pertain to various assessment years relating to the financial periods ending upto March 31, 2021, are fully recoverable upon completion of the assessment / disposal of the appeals pending in various forums. The refunds are withheld/under process on account of disputes pending before various forums and no impairment is considered necessary and further the Management expects a favourable outcome on the pending tax litigations. n
Textual Information(5) Refer Details of Audit Qualifications stated in Row 13
Textual Information(6) Considering the business operations of the Company are severely impacted as stated in Note No. 4 to the Statement, we are unable to comment on the usage/recoverability of indirect tax credit/receivables of INR 53.63 Million and the consequential impact, if any, on the total assets and loss as at and for the year then ended.
Textual Information(7) Not Applicable
Textual Information(8) Not Applicable
Textual Information(9) Management has actively engaged consultants to claim refunds where the same is allowed by Laws and balance amount can be carried forward and set off against any future tax liability that may arise once the business get revived. n
Textual Information(10) Refer Details of Audit Qualifications stated in Row 14
Textual Information(11) As stated in Note No. 4 to the Statement, the Company has incurred huge loss after tax of INR 697.36 Million for the year ended March 31, 2025 (INR 2072.51 Million for the year ended March 31, 2024) on account of divestment of Ecron Acunova Limited and recognition of impairment loss on certain financial assets resulting in substantial reduction in networth of the Company as on March 31, 2025. Further, significant deterioration in the value of the assets used to generate cash flows was seen over the last two years as evidenced by lower volume of business. In addition, the Company has significant litigations under direct tax law and the outcome & impact of which is unascertainable. Furthermore, the Company has significant unpaid statutory dues. The cumulative effect of these factors and the possible impact of the matters stated in paragraphs (a) & (b) above indicate the existence of a material uncertainty that may cast significant doubt on the Companys ability to continue as a going concern and therefore the Company may be unable to realize its assets and discharge its liabilities in the normal course of business. Despite the above factors, the Standalone Financial Results have been prepared on a going concern basis and no adjustment has been made to the carrying value of assets and liabilities, as the Company during the reporting period has successfully divested its 100% stake held in subsidiary Ecron Acunova Limited, the proceeds of which were available to meet the pending statutory and debt obligations of the subsidiary through this Financial Year. Further, the Company has pragmatically initiated conversations for diversification of operations to other verticals subject to current non-compete obligations applicable in the CRO industry. The companys strategy is to solicit mutually rewarding business partnerships/Mergers & Acquisitions in non-cash transactions and a positive closure of the deal is expected in the Financial Year 2026. While the plans for diversification of operations to other verticals are under discussion, the consequential impact on the going concern assumption is not ascertainable at this stage in the absence of detailed managements assessment on the entitys going concern and hence we are unable to comment on whether the preparation of standalone financial results on a going concern basis is appropriate and on the consequential impact, if any, on the annual standalone financial results.
Textual Information(12) Not Applicable
Textual Information(13) Not Applicable
Textual Information(14) The Standalone Financial Results have been prepared on a going concern basis and no adjustment has been made to the carrying value of assets and liabilities, as the Company, during the reporting period has successfully divested its subsidiary Ecron Acunova Limited, the proceeds of which has addressed the immediate liquidity requirements to meet the pending statutory and debt obligations through this Financial Year and the Company has paid some of the statutory dues during the reporting period. Further, the Company has pragmatically initiated conversations for diversification of operations to other verticals as subject to current non-compete obligations applicable in the CRO industry. The companys strategy is to solicit mutually rewarding business partnerships/Mergers & Acquisitions in non-cash transactions and a positive closure of the deal is expected in the Financial Year 2026.
Textual Information(15) Refer Details of Audit Qualifications stated in Row 15


Signatories detail
Name of CEO / Managing director Cecily Dheepa
Name of CFO Vedamirtham Venkatesan
Name of audit committee chairman Pushpa Joshi
Name of statutory auditor V Vijay Krishna
Name of other signatory, if any, with designation
Place Chennai
Date 30-May-2025


Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)
Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity/subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of the related party transaction ratified by the audit committee Date of Audit Committee Meeting where the ratification was approved Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 TAKE Solutions Limited V.Venkatesan Chief Financial Officer Remuneration 6500000 NA 2550000 0 0
2 TAKE Solutions Limited Navitas LLP Subsidiary Any other transaction Advance given 20000000 NA -26050000 26930000 880000
3 TAKE Solutions Limited Navitas LLP Subsidiary Any other transaction Share of Loss -Profit and Loss item. 150000000 NA 96330000 0 0
4 TAKE Solutions Limited Navitas LLP Subsidiary Any other transaction Other payables 150000000 NA 148640000 -133390000 15250000
5 TAKE Solutions Limited Aakansha management Consultancy and Holding Pvt Ltd Subsidiary Any other transaction Expenses 10000000 NA 8990000 0 0
6 TAKE Solutions Limited V.Venkatesan Chief Financial Officer Any other transaction Professional Fees 10000000 NA 10000000 0 0
7 TAKE Solutions Limited Vaidehi Venkatesan Relative of KMP Any other transaction Professional Fees 10000000 NA 10000000 0 0
8 TAKE Solutions Limited G.RAMESH Director Any other transaction Expenses 200000 NA 200000 0 0
9 TAKE Solutions Limited R.SESHADRI Director Any other transaction Expenses 200000 NA 200000 0 0
10 TAKE Solutions Limited N. CHANDRASEKARAN Director Any other transaction Expenses 200000 NA 200000 0 0
11 TAKE Solutions Limited KIRAN SHARMA Director Any other transaction Expenses 200000 NA 200000 0 0
Total value of transaction during the reporting period 251260000